News about Industrial talks

AstraZeneca Partners with Algen Biopharmaceuticals in USD 555 Million Gene Therapy Deal

AstraZeneca Partners with Algen Biopharmaceuticals in USD 555 Million Gene Therapy Deal

AstraZeneca has entered into a collaboration and licence agreement valued at up to USD 555 million with United States–based biotechnology company Algen Biopharmaceuticals to develop gene therapies targeting rare diseases.

Industrial talks | 07/10/2025 | By Darshana 139

AbbVie Cuts 2025 Profit Forecast Following USD 2.7 Billion R&D Charge

AbbVie Cuts 2025 Profit Forecast Following USD 2.7 Billion R&D Charge

The company plans to reduce its adjusted earnings per share guidance to a range of USD 10.38 to USD 10.58, down from its prior forecast of USD 11.88 to USD 12.08.

Industrial talks | 06/10/2025 | By Darshana 344

Indian Pharmaceutical Alliance Welcomes New Leadership

Indian Pharmaceutical Alliance Welcomes New Leadership

Dr. Sharvil Patel, Managing Director, Zydus Lifesciences, and Vice President, Indian Pharmaceutical Alliance (IPA), has been appointed President of the alliance, while Glenn Saldanha, Chairman and Managing Director, Glenmark, will serve as the new Vice President.

Industrial talks | 04/10/2025 | By Dineshwori 120

Vidal Health and Serum Institute Offer Easy Digital Access to HPV Vaccines

Vidal Health and Serum Institute Offer Easy Digital Access to HPV Vaccines

Starting on 1 October, people will be able to use Vidal Health’s online platform to get the HPV vaccine easily and pay cashlessly. The new partnership with Serum Institute of India, the world’s biggest vaccine maker, aims to help the national effort against cervical cancer.

Industrial talks | 24/09/2025 | By Darshana 134

Jubilant Pharmova Appoints Arun Kumar Sharma as Interim CFO

Jubilant Pharmova Appoints Arun Kumar Sharma as Interim CFO

Jubilant Pharmova has Arun Kumar Sharma as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the company for an interim period, effective October 1, 2025. He will serve in this role until the appointment of a new CFO is finalised.

Industrial talks | 23/09/2025 | By Dineshwori

Minor Fire at Aurobindo Pharma's Andhra Pradesh Unit Causes Temporary Production Disruption

Minor Fire at Aurobindo Pharma's Andhra Pradesh Unit Causes Temporary Production Disruption

The incident occurred at Unit IV of APL Healthcare Ltd, located in Naidupeta, Andhra Pradesh (SEZ Unit), on 18 September 2025 at around 8:50 am. The cause was identified as a short circuit in granulation area-10.

Industrial talks | 22/09/2025 | By Darshana 116

Harvard Bioscience Expands Fisher Scientific Distribution Network in US

Harvard Bioscience Expands Fisher Scientific Distribution Network in US

The expansion covers the United States and adds more products to the line-up. Fisher Scientific will now distribute Harvard’s pumps, spectrophotometers, and BTX electroporation systems in the U.S. market, in addition to existing European markets.

Industrial talks | 17/09/2025 | By Darshana

India's Pharma 2.0: Moving Beyond Generics to Innovation

India's Pharma 2.0: Moving Beyond Generics to Innovation

For decades, India has been known as the “pharmacy of the world.” The country built this reputation on its strength in generics. Low-cost medicines from Indian companies reached millions across the globe. They helped make treatments affordable in developed and developing nations alike.

Industrial talks | 13/09/2025 | By Darshana 183

Alkermes appoints Joshua Reed as CFO

Alkermes appoints Joshua Reed as CFO

The newly-appointed CFO at Alkermes, Joshua Reed, brings over 30 years of financial leadership experience, with a strong focus in the biotechnology and pharmaceutical sectors. Most recently, he served as CFO of Omega Therapeutics.

Industrial talks | 13/09/2025 | By Dineshwori

Dr. Reddy's Acquires STUGERON Brand from Johnson & Johnson to Strengthen CNS Portfolio

Dr. Reddy's Acquires STUGERON Brand from Johnson & Johnson to Strengthen CNS Portfolio

Dr. Reddy’s, a global pharmaceutical company, has announced the completion of a definitive agreement with Johnson & Johnson to acquire STUGERON and its associated brands, STUGERON FORTE and STUGERON PLUS, across 18 markets in the Asia-Pacific (APAC) and Europe, Middle East and Africa (EMEA) regions.

Industrial talks | 11/09/2025 | By Darshana

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members